Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Current Issue
Current Issue
Email alerts
Current Issue
Prev issue
March 2024 - Volume 12 - 3
Basic tumor immunology
Original research: BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1
(14 March, 2024)
Young-Seung
Kim
,
Seung-Hoon
Lee
,
Andrew H
Park
,
Chunai
Wu
,
Bong-Ki
Hong
,
Hyunjin
Jung
,
Steven H
Lin
,
Stephen S
Yoo
Original research: Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates
(13 March, 2024)
Arabinda
Mandal
,
Jagathpala
Shetty
,
Christine A
Tran
,
Walter C
Olson
,
Mriganka
Mandal
,
Bhupal
Ban
,
Eusebio S
Pires
,
Sara J
Adair
,
Todd W
Bauer
,
Craig L
Slingluff
,
John C
Herr
Original research: rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors
(12 March, 2024)
Minji
Lee
,
Sun-Kyoung
Im
,
Seungtae
Baek
,
Mankyu
Ji
,
Miyoung
Kim
,
Eun Ju
Lee
,
Seung Taek
Ji
,
Sara
Ferrando-Martinez
,
Alexandra
Wolfarth
,
Jun-Young
Lee
,
Daeun
Kim
,
Donghoon
Choi
Original research: Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases
(7 March, 2024)
Friederike
Oltmanns
,
Ana
Vieira Antão
,
Pascal
Irrgang
,
Vera
Viherlehto
,
Leticia
Jörg
,
Anna
Schmidt
,
Jannik T
Wagner
,
Michael
Rückert
,
Ann-Sophie
Flohr
,
Carol Imanuel
Geppert
,
Benjamin
Frey
,
Wibke
Bayer
,
Claudia
Gravekamp
,
Matthias
Tenbusch
,
Udo
Gaipl
,
Dennis
Lapuente
Original research: Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells
(7 March, 2024)
Ian-Ian
Ng
,
Jiaqi
Zhang
,
Tingzhong
Tian
,
Qi
Peng
,
Zheng
Huang
,
Kaimin
Xiao
,
Xiyue
Yao
,
Lui
Ng
,
Jianyang
Zeng
,
Haidong
Tang
Original research: Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells
(7 March, 2024)
Monica
Parodi
,
Giovanni
Centonze
,
Fabio
Murianni
,
Paola
Orecchia
,
Francesca
Andriani
,
Ilaria
Roato
,
Cecilia
Gardelli
,
Melissa
Balsamo
,
Massimo
Moro
,
Giulia
Taiè
,
Ugo
Pastorino
,
Andrea
Petretto
,
Chiara
Lavarello
,
Massimo
Milione
,
Gabriella
Sozzi
,
Luca
Roz
,
Massimo
Vitale
,
Giulia
Bertolini
Original research: Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer
(1 March, 2024)
Yun
Zhou
,
Wenyao
Zhang
,
Boda
Wang
,
Pei
Wang
,
Danxiu
Li
,
Tianyu
Cao
,
Dawei
Zhang
,
Hua
Han
,
Mingfeng
Bai
,
Xin
Wang
,
Xiaodi
Zhao
,
Yuanyuan
Lu
Clinical/translational cancer immunotherapy
Original research: Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
(13 March, 2024)
Ju Won
Kim
,
Hyo Jin
Lee
,
Ji Yoon
Lee
,
Sook Ryun
Park
,
Yu Jung
Kim
,
In Gyu
Hwang
,
Woo
Kyun Bae
,
Jae Ho
Byun
,
Jung Sun
Kim
,
Eun Joo
Kang
,
Jeeyun
Lee
,
Sang Joon
Shin
,
Won Jin
Chang
,
Eun-Ok
Kim
,
Jason K
Sa
,
Kyong Hwa
Park
Original research: Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer
(13 March, 2024)
Arun
Rajan
,
Houssein
Abdul Sater
,
Osama
Rahma
,
Richy
Agajanian
,
Wiem
Lassoued
,
Jennifer L
Marté
,
Yo-Ting
Tsai
,
Renee N
Donahue
,
Elizabeth
Lamping
,
Shania
Bailey
,
Andrew
Weisman
,
Beatriz
Walter-Rodriguez
,
Rena
Ito
,
Yulia
Vugmeyster
,
Masashi
Sato
,
Andreas
Machl
,
Jeffrey
Schlom
,
James L
Gulley
Original research: Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial
(13 March, 2024)
Heinz-Josef
Lenz
,
Aparna
Parikh
,
David R
Spigel
,
Allen L
Cohn
,
Takayuki
Yoshino
,
Mark
Kochenderfer
,
Elena
Elez
,
Spencer H
Shao
,
Dustin
Deming
,
Regan
Holdridge
,
Timothy
Larson
,
Eric
Chen
,
Amit
Mahipal
,
Antonio
Ucar
,
Dana
Cullen
,
Edwina
Baskin-Bey
,
Tong
Kang
,
Amy B
Hammell
,
Jin
Yao
,
Josep
Tabernero
Original research: Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
(13 March, 2024)
Dirk
Schadendorf
,
Jason John
Luke
,
Paolo A
Ascierto
,
Georgina V
Long
,
Piotr
Rutkowski
,
Adnan
Khattak
,
Michele
Del Vecchio
,
Luis
de la Cruz-Merino
,
Jacek
Mackiewicz
,
Vanna Chiarion
Sileni
,
John M
Kirkwood
,
Caroline
Robert
,
Jean-Jacques
Grob
,
Reinhard
Dummer
,
Matteo S
Carlino
,
Yujie
Zhao
,
Mizuho
Kalabis
,
Clemens
Krepler
,
Alexander
Eggermont
,
Richard A
Scolyer
Original research: Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors
(11 March, 2024)
Qian
Tao
,
Nian
Liu
,
Jie
Wu
,
Jing
Chen
,
Xiang
Chen
,
Cong
Peng
Original research: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
(11 March, 2024)
Danny
Rischin
,
Brett G M
Hughes
,
Nicole
Basset-Séguin
,
Dirk
Schadendorf
,
Samantha
Bowyer
,
Sabiha
Trabelsi Messai
,
Friedegund
Meier
,
Thomas K
Eigentler
,
Victoria
Casado Echarren
,
Brian
Stein
,
Marie
Beylot-Barry
,
Sophie
Dalac
,
Brigitte
Dréno
,
Michael R
Migden
,
Axel
Hausschild
,
Chrysalyne D
Schmults
,
Annette M
Lim
,
Suk-Young
Yoo
,
Anne J
Paccaly
,
Apostolos
Papachristos
,
Jenny-Hoa
Nguyen
,
Emmanuel
Okoye
,
Frank
Seebach
,
Jocelyn
Booth
,
Israel
Lowy
,
Matthew G
Fury
,
Alexander
Guminski
Original research: Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
(7 March, 2024)
Katsuhiko
Nara
,
Satoru
Taguchi
,
Sebastiano
Buti
,
Taketo
Kawai
,
Yukari
Uemura
,
Takehito
Yamamoto
,
Haruki
Kume
,
Tappei
Takada
Original research: Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer
(7 March, 2024)
Xin
Xu
,
Zhiyong
Sun
,
Qiang
Liu
,
Yao
Zhang
,
Lei
Shen
,
Chenpeng
Zhang
,
Haiping
Lin
,
Bin
Hu
,
Ling
Rong
,
Haiyan
Chen
,
Xiaohang
Wang
,
Xiaojing
Zhao
,
Yong-Rui
Bai
,
Qing
Ye
,
Xiumei
Ma
Original research: Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
(7 March, 2024)
Nikhil I
Khushalani
,
Patrick A
Ott
,
Robert L
Ferris
,
Tina
Cascone
,
Dirk
Schadendorf
,
Dung T
Le
,
Manish R
Sharma
,
Fabrice
Barlesi
,
William
Sharfman
,
Jason J
Luke
,
Ignacio
Melero
,
Deanne
Lathers
,
Jaclyn
Neely
,
Satyendra
Suryawanshi
,
Abanti
Sanyal
,
James L
Holloway
,
Rasika
Suryawanshi
,
Scott
Ely
,
Neil H
Segal
Original research: Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
(5 March, 2024)
Amin H
Nassar
,
Talal
El Zarif
,
Ahmed Bilal
Khalid
,
Serena
Rahme
,
Caiwei
Zhong
,
Lucia
Kwak
,
Marita
Salame
,
Elias Bou
Farhat
,
Dory
Freeman
,
Edward
El-Am
,
Arjun
Ravishankar
,
Bachar
Ahmad
,
Frank Aboubakar
Nana
,
David
Kaldas
,
Abdul Rafeh
Naqash
,
Elad
Sharon
,
Nicole R
LeBoeuf
,
Alessio
Cortellini
,
Andrea
Malgeri
,
Shruti
Gupta
,
Ahmad
Al-Hader
,
Jeffrey A
Sparks
,
Jenny
Linnoila
,
Ole-Petter R
Hamnvik
,
Tarek H
Mouhieddine
,
Thomas
Marron
,
Kaushal
Parikh
,
Rana R
McKay
,
Thomas
Dilling
,
Toni K
Choueiri
,
Elio
Adib
,
Elie
Najem
,
So Yeon
Kim
,
Guru
Sonpavde
Commentary
Key role of CD4+ T cells in determining CD8 function during CAR-T cell manufacture
(13 March, 2024)
J Joseph
Melenhorst
,
Beatriz C
Oliveira
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?
(13 March, 2024)
Robert J
Canter
,
Sean J
Judge
,
Craig P
Collins
,
Daniel Jaeho
Yoon
,
William J
Murphy
Immunotherapy biomarkers
Original research: Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
(4 March, 2024)
Hesong
Zou
,
Wei
Liu
,
Xiaojuan
Wang
,
Yi
Wang
,
Chunyang
Wang
,
Chen
Qiu
,
Huimin
Liu
,
Dandan
Shan
,
Ting
Xie
,
Wenyang
Huang
,
Weiwei
Sui
,
Shuhua
Yi
,
Gang
An
,
Yan
Xu
,
Tonghui
Ma
,
Jianxiang
Wang
,
Lugui
Qiu
,
Dehui
Zou
Immune cell therapies and immune cell engineering
Original research: Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice
(15 March, 2024)
Shahryar
Khoshtinat Nikkhoi
,
Ge
Yang
,
Hajar
Owji
,
Mayara
Grizotte-Lake
,
Rick I
Cohen
,
Lazaro
Gil Gonzalez
,
Mohammad
Massumi
,
Arash
Hatefi
Oncolytic and local immunotherapy
Original research: Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
(8 March, 2024)
Sara
Feola
,
Firas
Hamdan
,
Salvatore
Russo
,
Jacopo
Chiaro
,
Manlio
Fusciello
,
Michaela
Feodoroff
,
Gabriella
Antignani
,
Federica
D'Alessio
,
Riikka
Mölsä
,
Virpi
Stigzelius
,
Paolo
Bottega
,
Sari
Pesonen
,
Jeanette
Leusen
,
Mikaela
Grönholm
,
Vincenzo
Cerullo
Original research: An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy
(7 March, 2024)
Shibing
Wang
,
Yuxin
Li
,
Chuning
Xu
,
Jie
Dong
,
Jiwu
Wei
Review
Biomarkers for response to TIL therapy: a comprehensive review
(13 March, 2024)
Víctor
Albarrán Fernández
,
Pablo
Ballestín Martínez
,
Joachim
Stoltenborg Granhøj
,
Troels Holz
Borch
,
Marco
Donia
,
Inge
Marie Svane
Correction
Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma
(5 March, 2024)
Commentary